Author: aveak

Xconomy Wisconsin — Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing. Twenty-three investors participated in the equity funding round, according to the filing, which was made public...

UW-Madison's Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing. The grant was announced yesterday at the Biohealth Summit by Professor Bill Murphy, the institute's director. "This is a unique public-private collaboration that's committed to advancing the global biomanufacturing...

The recently announced Forward BIOLABS will serve as a landing place for startups, many of which will come out of UW-Madison research. That’s according to co-founder Jessica Martin Eckerly. She says the nonprofit’s goal is to establish a fully equipped life sciences laboratory for early-stage companies,...

An eight-year quest to find the cause of a disease has apparently ended now that scientists at UW-Madison have identified the mutations that produce a form of myelofibrosis, a rare genetic blood disorder. Mutations in a protein that controls the production of blood platelets appear to...

Ten winners winners were honored from the thirty-three finalists and more than 350 nominees during the 2018 Wisconsin Innovation Awards at the Wisconsin Union Terrace. The ceremony, emceed by local entrepreneur and Filament Games Vice President of Sales, Jennifer Javornik recognized the state’s most innovative products...

Biochemistry assistant professor Srivatsan “Vatsan” Raman has received a Director's New Innovator Award from the National Institutes of Health (NIH). The $2.2 million-grants fund high-risk, high-reward research performed by early stage investigators. Compared to traditional NIH grants, the New Innovator Award supports “unusually creative early stage investigators” whose research can have...

An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health. The test began in August, according to a statement last week by the National Institute...

Loading new posts...
No more posts